The application of exosomes as a nanoscale cancer vaccine

References

• World Health OrganizationCancer http://www.who.int/mediacentre/factsheets/fs297/en/index.html. Updated Feb 2009Accessed 2010 Jun 6
   Google Scholar
• CouzinJCell biology: the ins and outs of exosomesScience200530857301862186315976285
   PubMed Web of Science ®Google Scholar
• IeroMValentiRHuberVTumour-released exosomes and their implications in cancer immunityCell Death Differ2008151808817932500
   PubMed Web of Science ®Google Scholar
• SimpsonRJJensenSSLimJWProteomic profiling of exosomes: current perspectivesProteomics20088194083409918780348
   PubMed Web of Science ®Google Scholar
• TheryCOstrowskiMSeguraEMembrane vesicles as conveyors of immune responsesNat Rev Immunol20099858159319498381
   PubMed Web of Science ®Google Scholar
• Exosome protein and RNA databaseExoCarta Available from: http://exocarta.ludwig.edu.au/. Updated 2010 March 29Accessed 2010 Jun 23
   Google Scholar
• MathivananSSimpsonRJExoCarta: a compendium of exosomal proteins and RNAProteomics20099214997500019810033
   PubMed Web of Science ®Google Scholar
• MalamYLoizidouMSeifalianAMLiposomes and nanoparticles: nanosized vehicles for drug delivery in cancerTrends Pharmacol Sci2009301159259919837467
   PubMed Web of Science ®Google Scholar
• LeonardRCWilliamsSTulpuleALevineAMOliverosSImproving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet)Breast200918421822419656681
   PubMed Web of Science ®Google Scholar
• PetrelliFBorgonovoKBarniSTargeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxelExpert Opin Pharmacother20101181413143220446855
   PubMed Web of Science ®Google Scholar
• ZolnikBSGonzalez-FernandezASadriehNDobrovolskaiaMANanoparticles and the immune systemEndocrinology2010151245846520016026
   PubMed Web of Science ®Google Scholar
• ScheerlinckJPGreenwoodDLVirus-sized vaccine delivery systemsDrug Discov Today2008131920882887
   Web of Science ®Google Scholar
• RiegerJFreichelsHImbertyAPolyester nanoparticles presenting mannose residues: toward the development of new vaccine delivery systems combining biodegradability and targeting propertiesBiomacromolecules200910365165719203184
   PubMed Web of Science ®Google Scholar
• SeowYWoodMJBiological gene delivery vehicles: beyond viral vectorsMol Ther200917576777719277019
   PubMed Web of Science ®Google Scholar
• BiernackiMAMarinaOZhangWEfficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cellsCancer Res201070390691520103624
   PubMed Web of Science ®Google Scholar
• LeRQBevansMSavaniBNFavorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignanciesBiol Blood Marrow Transplant20101681162117020302959
   PubMed Web of Science ®Google Scholar
• GarlandSMSmithJSHuman papillomavirus vaccines: current status and future prospectsDrugs20107091079109820518577
   PubMed Web of Science ®Google Scholar
• KenterGGWeltersMJValentijnARVaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasiaN Engl J Med2009361191838184719890126
   PubMed Web of Science ®Google Scholar
• JainiRKesarajuPJohnsonJMAltuntasCZJane-WitDTuohyVKAn autoimmune-mediated strategy for prophylactic breast cancer vaccinationNat Med201016779980320512124
   PubMed Web of Science ®Google Scholar
• ChenDSToward elimination and eradication of hepatitis BJ Gastroenterol Hepatol2010251192520136972
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationFDA approves a cellular immunotherapy for men with advanced prostate cancer Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm210174.htm. Updated 2010 Apr 29Accessed 2010 Jun 6
   Google Scholar
• HarzstarkALSmallEJImmunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge)Expert Opin Biol Ther2007781275128017696825
   PubMed Web of Science ®Google Scholar
• Rethinking therapeutic cancer vaccinesNat Rev Drug Discov20098968568619721436
   PubMed Web of Science ®Google Scholar
• BanchereauJPaluckaAKDendritic cells as therapeutic vaccines against cancerNat Rev Immunol20055429630615803149
   PubMed Web of Science ®Google Scholar
• WeinbergRThe Biology of Cancer1st edLondon, UKGarland Science2007
   Google Scholar
• GrivennikovSIGretenFRKarinMImmunity, inflammation, and cancerCell2010140688389920303878
   PubMed Web of Science ®Google Scholar
• DelvesPJMatinSJBurtonDRRoittIMTumour immunologyRoitt’s Essential Immunology11th edOxford, UKBlackwell Publishing2009402
   Google Scholar
• HanselTTKropshoferHSingerTMitchellJAGeorgeAJThe safety and side effects of monoclonal antibodiesNat Rev Drug Discov20109432533820305665
   PubMed Web of Science ®Google Scholar
• FujiiSTakayamaTAsakuraMAkiKFujimotoKShimizuKDendritic cell-based cancer immunotherapiesArch Immunol Ther Exp (Warsz)200957318919819479202
   PubMed Web of Science ®Google Scholar
• KimJVLatoucheJBRiviereISadelainMThe ABCs of artificial antigen presentationNat Biotechnol200422440341015060556
   PubMed Web of Science ®Google Scholar
• KoosDJosephsSFAlexandrescuDTTumor vaccines in 2010: need for integrationCell Immunol2010263213814720434139
   PubMed Web of Science ®Google Scholar
• SasadaTKomatsuNSuekaneSYamadaANoguchiMItohKOvercoming the hurdles of randomised clinical trials of therapeutic cancer vaccinesEur J Cancer20104691514151920413296
   PubMed Web of Science ®Google Scholar
• TanneJHFDA approves prostate cancer “vaccine”BMJ2010340c243120442242
   PubMed Web of Science ®Google Scholar
• BuNLiQLFengQSunBZImmune protection effect of exosomes against attack of L1210 tumor cellsLeuk Lymphoma200647591391816753878
   PubMed Web of Science ®Google Scholar
• AndreFSchartzNEMovassaghMMalignant effusions and immunogenic tumour-derived exosomesLancet2002360932929530512147373
   PubMed Web of Science ®Google Scholar
• ChoJAYeoDJSonHYExosomes: a new delivery system for tumor antigens in cancer immunotherapyInt J Cancer2005114461362215609328
   PubMed Web of Science ®Google Scholar
• SkogJWurdingerTvan RijnSGlioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNat Cell Biol200810121470147619011622
   PubMed Web of Science ®Google Scholar
• ChoJALeeYSKimSHKoJKKimCWMHC independent antitumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine modelsCancer Lett2009275225626519036499
   PubMed Web of Science ®Google Scholar
• XieYBaiOZhangHMembrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumor immunity than exosomes released from heat-shocked tumor cells expressing cytoplasmic HSP70J Cell Mol Med2009720 [Epub ahead of print]
   Web of Science ®Google Scholar
• ZeelenbergISOstrowskiMKrumeichSTargeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responsesCancer Res20086841228123518281500
   PubMed Web of Science ®Google Scholar
• RistorcelliEBeraudEMathieuSLombardoDVerineAEssential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticlesInt J Cancer200912551016102619405120
   PubMed Web of Science ®Google Scholar
• RistorcelliEBeraudEVerrandoPHuman tumor nanoparticles induce apoptosis of pancreatic cancer cellsFASEB J20082293358336918511551
   PubMed Web of Science ®Google Scholar
• WolfersJLozierARaposoGTumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-primingNat Med20017329730311231627
   PubMed Web of Science ®Google Scholar
• TemchuraVVTenbuschMNchindaGEnhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virusVaccine200826293036623672
   Web of Science ®Google Scholar
• YangYXiuFCaiZIncreased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cellsJ Cancer Res Clin Oncol2007133638939917219198
   PubMed Web of Science ®Google Scholar
• ZitvogelLRegnaultALozierAEradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomesNat Med1998455946009585234
   PubMed Web of Science ®Google Scholar
• AndreFChaputNSchartzNEExosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cellsJ Immunol200417242126213614764678
   PubMed Web of Science ®Google Scholar
• BeauvillainCRuizSGuitonRBoutDDimier-PoissonIA vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic miceMicrobes Infect20079141516141622
   Web of Science ®Google Scholar
• GuoFChangCKFanHHAnti-tumour effects of exosomes in combination with cyclophosphamide and polyinosinic-polycytidylic acidJ Int Med Res20083661342135319094445
   PubMed Web of Science ®Google Scholar
• HaoSBaiOYuanJQureshiMXiangJDendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomesCell Mol Immunol20063320521116893501
   PubMed Web of Science ®Google Scholar
• HaoSBaiOLiFYuanJLaferteSXiangJMature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunityImmunology200712019010217073943
   PubMed Web of Science ®Google Scholar
• TaiebJChaputNSchartzNChemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccinesJ Immunol200617652722272916493027
   PubMed Web of Science ®Google Scholar
• HegmansJPHemmesAAertsJGHoogstedenHCLambrechtBNImmunotherapy of murine malignant mesothelioma using tumor lysatepulsed dendritic cellsAm J Respir Crit Care Med2005171101168117715764728
   PubMed Web of Science ®Google Scholar
• ViaudSTermeMFlamentCDendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15RalphaPLoS One200943e494219319200
   PubMed Web of Science ®Google Scholar
• HaoSYeZYangJBaiOXiangJIntradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunityCancer Biother Radiopharm200621214615416706635
   PubMed Web of Science ®Google Scholar
• DaiSWeiDWuZPhase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancerMol Ther200816478279018362931
   PubMed Web of Science ®Google Scholar
• EscudierBDorvalTChaputNVaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trialJ Transl Med2005311015740633
   PubMed Web of Science ®Google Scholar
• MorseMAGarstJOsadaTA phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancerJ Transl Med200531915723705
   PubMed Web of Science ®Google Scholar
• XiuFCaiZYangYWangXWangJCaoXSurface anchorage of superantigen SEA promotes induction of specific antitumor immune response by tumor-derived exosomesJ Mol Med200785551152117219095
   PubMed Web of Science ®Google Scholar
• ChenWWangJShaoCEfficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cellsEur J Immunol20063661598160716708399
   PubMed Web of Science ®Google Scholar
• DaiSWanTWangBMore efficient induction of HLA-A*0201- restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cellsClin Cancer Res200511207554756316243831
   PubMed Web of Science ®Google Scholar
• ChaputNSchartzNEAndreFExosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejectionJ Immunol200417242137214614764679
   PubMed Web of Science ®Google Scholar
• KostarelosKBiancoAPratoMPromises, facts and challenges for carbon nanotubes in imaging and therapeuticsNat Nanotechnol200941062763319809452
   PubMed Web of Science ®Google Scholar
• MengJMengJDuanJCarbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapySmall2008491364137018720440
   PubMed Web of Science ®Google Scholar
• PantarottoDPartidosCDHoebekeJImmunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responsesChem Biol2003101096196614583262
   PubMedGoogle Scholar
• FadelTRSteenblockERSternEEnhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuliNano Lett2008872070207618547120
   PubMed Web of Science ®Google Scholar
• van SchooneveldMMGloterAStephanOImaging and quantifying the morphology of an organic-inorganic nanoparticle at the sub-nanometre levelNat Nanotechnol20105753854420526325
   PubMed Web of Science ®Google Scholar
• IgaAMRobertsonJHWinsletMCSeifalianAMClinical potential of quantum dotsJ Biomed Biotechnol20072007107608718317518
   PubMedGoogle Scholar
• JamiesonTBakhshiRPetrovaDPocockRImaniMSeifalianAMBiological applications of quantum dotsBiomaterials200728314717473217686516
   PubMed Web of Science ®Google Scholar
• de La ZerdaAGambhirSSDrug delivery: keeping tabs on nanocarriersNat Nanotechnol200721274574618654423
   PubMed Web of Science ®Google Scholar
• de La PenaHMadrigalJARusakiewiczSArtificial exosomes as tools for basic and clinical immunologyJ Immunol Methods2009344212113219345222
   PubMed Web of Science ®Google Scholar